103 related articles for article (PubMed ID: 6323854)
1. Class I antibody induction by rat endothelium.
Goldman MH; Tuttle-Fuller N; Salim J; Bendheim S; Mohanakumar T
J Surg Res; 1984 Apr; 36(4):327-31. PubMed ID: 6323854
[TBL] [Abstract][Full Text] [Related]
2. Expression of RT1.A and RT1.B/D antigens on endothelium of rat kidneys.
Paul LC; Paradysz JM; Milford EL; Kunz HW; Carpenter CB
Transplantation; 1982 Sep; 34(3):121-8. PubMed ID: 6753270
[TBL] [Abstract][Full Text] [Related]
3. Genetics of the antibody response to an endothelial transplantation antigen in the rat.
Blankert JJ; van Es LA; Kunz HW; Cramer DV; Paul LC
Hum Immunol; 1986 Feb; 15(2):125-36. PubMed ID: 3949552
[TBL] [Abstract][Full Text] [Related]
4. The relative immunogenicity of corneal epithelium, stroma, and endothelium. The role of major histocompatibility complex antigens.
Treseler PA; Foulks GN; Sanfilippo F
Transplantation; 1986 Feb; 41(2):229-34. PubMed ID: 3511584
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
[TBL] [Abstract][Full Text] [Related]
6. Induction of indirect donor-specific hyporesponsiveness by transportal RT1-peptide pulse in rat skin transplantation.
Yamamura M; Yagi T; Iwagaki H; Mitsuoka N; Jie L; Sheng SD; Matsuda H; Sadamori H; Inagaki M; Tanaka N
Transpl Int; 2003 Aug; 16(8):451-5. PubMed ID: 12719799
[TBL] [Abstract][Full Text] [Related]
7. Allospecific monoclonal antibodies recognizing rat class I and class II histocompatibility antigens.
Engel EE; Guttmann RD; Fuks A
Transplantation; 1982 Jun; 33(6):631-5. PubMed ID: 6179272
[TBL] [Abstract][Full Text] [Related]
8. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
Wasowska B; Baldwin WM; Sanfilippo F
Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
[TBL] [Abstract][Full Text] [Related]
9. Relative contribution of major histocompatibility complex antigens to the immunogenicity of corneal allografts.
Treseler PA; Sanfilippo F
Transplantation; 1986 Apr; 41(4):508-14. PubMed ID: 3515652
[TBL] [Abstract][Full Text] [Related]
10. The expression of major histocompatibility complex and leukocyte antigens by cells in the rat cornea.
Treseler PA; Sanfilippo F
Transplantation; 1986 Feb; 41(2):248-52. PubMed ID: 3456178
[TBL] [Abstract][Full Text] [Related]
11. Prolonged cold ischemic times and less donor-recipient histocompatibility accelerate graft vascular disease.
Czer LS; Wong AV; Soukiasian H; Gallagher S; De Robertis M; Trento A
Transplant Proc; 2011 Dec; 43(10):3863-8. PubMed ID: 22172861
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection.
Forbes RD; Parfrey NA; Gomersall M; Darden AG; Guttmann RD
J Exp Med; 1986 Oct; 164(4):1239-58. PubMed ID: 3531383
[TBL] [Abstract][Full Text] [Related]
13. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
[TBL] [Abstract][Full Text] [Related]
14. Use of allochimeric proteins to mitigate graft-versus-host and host-versus-graft immune responses to rat small bowel allografts.
Okamoto M; Stepkowski SM; Wang M; Kahan BD
Transplantation; 2000 Oct; 70(7):1060-7. PubMed ID: 11045643
[TBL] [Abstract][Full Text] [Related]
15. Allochimeric class I MHC molecules prevent chronic rejection and attenuate alloantibody responses.
Singer JS; Mhoyan A; Fishbein MC; Shen XD; Gao F; Zhao D; Coito AJ; Reemtsen BL; Amersi F; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
Transplantation; 2001 Oct; 72(8):1408-16. PubMed ID: 11685113
[TBL] [Abstract][Full Text] [Related]
16. Use of donor serum to prevent passive transfer of hyperacute rejection.
Wang J; Geissler EK; Fechner JH; Burlingham WJ; Knechtle SJ
J Surg Res; 1994 Jul; 57(1):150-5. PubMed ID: 8041130
[TBL] [Abstract][Full Text] [Related]
17. Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules.
Ghobrial RR; Hamashima T; Wang ME; Wang M; Stepkowski SM; Kahan BD
Transplantation; 1996 Oct; 62(7):1002-10. PubMed ID: 8878396
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation of vascular endothelium: effects of ultraviolet B irradiation on vein allograft rejection.
Marin ML; Hardy MA; Gordon RE; Reemtsma K; Benvenisty AI
J Vasc Surg; 1990 Jan; 11(1):103-11. PubMed ID: 2296091
[TBL] [Abstract][Full Text] [Related]
19. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
Goss JA; Nakafusa Y; Flye MW
Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
[TBL] [Abstract][Full Text] [Related]
20. Intensity of transplant chronic rejection correlates with level of graft-infiltrating regulatory cells.
Semiletova NV; Shen XD; Baibakov B; Andakyan A
J Heart Lung Transplant; 2010 Mar; 29(3):335-41. PubMed ID: 20080050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
